| Loss of miR-145 promotes remyelination and functional recovery in a model of chronic central demyelination SF Kornfeld, SE Cummings, R Yaworski, Y De Repentigny, S Gagnon, ... Communications Biology 7 (1), 813, 2024 | | 2024 |
| The Blood–Brain Barrier: Composition, Properties, and Roles in Brain Health B Lacoste, A Prat, M Freitas-Andrade, C Gu Cold Spring Harbor Perspectives in Biology, a041422, 2024 | | 2024 |
| A multi-centre longitudinal study analysing multiple sclerosis disease-modifying therapy prescribing patterns during the COVID-19 pandemic AP Lal, YC Foong, PG Sanfilippo, T Spelman, L Rath, D Levitz, ... Journal of Neurology, 1-12, 2024 | | 2024 |
| The functional and pathogenic consequences of fibrinogen on human oligodendroglia GJ Blaszczyk, C Weng, A Mohammadnia, QL Cui, A Giurleo, AMR Groh, ... bioRxiv, 2024.05. 27.596068, 2024 | | 2024 |
| Sustained IFN signaling is associated with delayed development of SARS-CoV-2-specific immunity E Brunet-Ratnasingham, S Morin, HE Randolph, M Labrecque, J Bélair, ... Nature Communications 15 (1), 4177, 2024 | 2 | 2024 |
| Disease-modifying therapies in managing disability worsening in paediatric-onset multiple sclerosis: a longitudinal analysis of global and national registries S Sharmin, I Roos, CB Malpas, P Iaffaldano, M Simone, M Filippi, ... The Lancet Child & Adolescent Health 8 (5), 348-357, 2024 | 2 | 2024 |
| Identity and nature of neural stem cells in the adult human subventricular zone S Baig, J Nadaf, R Allache, PU Le, M Luo, A Djedid, A Nkili-Meyong, ... Iscience 27 (4), 2024 | 1 | 2024 |
| Disease-associated astrocyte epigenetic memory promotes CNS pathology HG Lee, JM Rone, Z Li, CF Akl, SW Shin, JH Lee, LE Flausino, F Pernin, ... Nature 627 (8005), 865-872, 2024 | 8 | 2024 |
| Regulation of stress granule formation in human oligodendrocytes F Pernin, QL Cui, A Mohammadnia, MGF Fernandes, JA Hall, M Srour, ... Nature Communications 15 (1), 1524, 2024 | 1 | 2024 |
| The blood-brain barrier in multiple sclerosis B Zierfuss, M Charabati, BA MacVicar, S Zandee, A Prat Mechanisms of Disease Pathogenesis in Multiple Sclerosis, 307-354, 2024 | | 2024 |
| Long-term clinical outcomes in patients with multiple sclerosis who are initiating disease-modifying therapy with natalizumab compared with BRACETD first-line therapies H Butzkueven, T Kalincik, F Patti, M Slee, B Weinstock-Guttman, ... Therapeutic Advances in Neurological Disorders 17, 17562864231221331, 2024 | | 2024 |
| Blood–brain barrier dysfunction in multiple sclerosis: Causes, consequences, and potential effects of therapies B Zierfuss, C Larochelle, A Prat The Lancet Neurology 23 (1), 95-109, 2024 | 4 | 2024 |
| ALCAM on human oligodendrocytes mediates CD4 T cell adhesion H Jamann, HL Desu, QL Cui, A Halaweh, O Tastet, W Klement, S Zandee, ... Brain 147 (1), 147-162, 2024 | 4 | 2024 |
| Investigation of Changes in Lymphocyte Subset Counts and their Relationship with MRI Outcomes in the Magnify-MS Study S Hodgkinson, T Derfuss, F Sellebjerg, P Vermersch, F Barkhof, ... Multiple Sclerosis and Related Disorders 80, 105237, 2023 | 1 | 2023 |
| Risk of secondary progressive multiple sclerosis after early worsening of disability W Dzau, S Sharmin, F Patti, G Izquierdo, S Eichau, A Prat, M Girard, ... Journal of Neurology, Neurosurgery & Psychiatry 94 (12), 984-991, 2023 | 2 | 2023 |
| Effectiveness of multiple disease-modifying therapies in relapsing-remitting multiple sclerosis: causal inference to emulate a multiarm randomised trial I Diouf, CB Malpas, S Sharmin, I Roos, D Horakova, EK Havrdova, F Patti, ... Journal of Neurology, Neurosurgery & Psychiatry 94 (12), 1004-1011, 2023 | 2 | 2023 |
| Gaining Biological Insights through Supervised Data Visualization JS Rhodes, A Aumon, S Morin, M Girard, C Larochelle, ... bioRxiv, 2023.11. 22.568384, 2023 | 1 | 2023 |
| CNS therapeutics: Immune cells break the barriers K Thai, A Prat Science Translational Medicine 15 (721), eadh1150, 2023 | | 2023 |
| The risk of secondary progressive multiple sclerosis is geographically determined but modifiable S Sharmin, I Roos, S Simpson-Yap, C Malpas, MM Sánchez, S Ozakbas, ... Brain 146 (11), 4633-4644, 2023 | 5 | 2023 |
| CanProCo Study; Examining Prognostic Protein Biomarkers in Sera and Plasma from Multiple Sclerosis Patients F Tea, O Tastet, L Bourbonniere, A Aumon, RM Rebillard, W Klement, ... MULTIPLE SCLEROSIS JOURNAL 29, 560-561, 2023 | | 2023 |
